
PDE5 inhibitors, the class most people know, work by increasing blood flow. They are effective for the mechanical side of sexual function and do nothing for desire. PT-141, generically bremelanotide, activates melanocortin receptors in the central nervous system, a pathway involved in sexual desire itself. Bremelanotide is FDA-approved under the brand name Vyleesi for hypoactive sexual desire disorder in premenopausal women; use in men or in other populations is off-label, and we state that plainly. At Bodyloom Wellness in Frisco, Texas, it is prescribed after a clinical consultation that treats low desire as a symptom with causes worth identifying rather than a problem to medicate around.



Your journey begins with a private consultation. We review health history, current medications, hormone status, sleep, stress, and what has changed and when. We understand this is not an easy thing to bring up, and it is a conversation we have often and handle with care.
Depending on your history, your provider may order bloodwork before prescribing, commonly including hormone panels and thyroid markers. If your labs point to a treatable cause such as low testosterone or thyroid dysfunction, we address that first rather than layering a peptide on top of it.
If PT-141 is appropriate, your provider writes the prescription and explains dosing, timing ahead of anticipated activity, maximum frequency, and what to expect. You will be taught to self-administer the subcutaneous injection, and the side effect profile is reviewed with you in full.
We follow up to assess response and tolerability. Nausea is the most frequently reported effect and is often dose related, so early adjustments are common and usually resolve it. Your provider will fine-tune until it works comfortably for you.

PT-141 pricing is dose dependent and depends on the protocol your provider prescribes and how frequently you expect to use it. We quote after your consultation rather than publishing a flat number. Any lab work and follow-up visits are priced separately. Bodyloom VIP Members receive preferred rates, and financing is available through Cherry and CareCredit.

Completely different mechanisms. PDE5 inhibitors increase blood flow and address the mechanical side of sexual function. PT-141 acts on melanocortin receptors in the central nervous system, a pathway associated with desire itself. If your issue is mechanical, a PDE5 inhibitor is the right tool and we will tell you so.
Bremelanotide is FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. Use in men or other populations is off-label. Off-label prescribing is legal and common, and we would rather state the boundary clearly than let an approval imply more than it covers.
It is prescribed for both. The FDA approval covers premenopausal women specifically; use in men is off-label and is based on clinical experience and the underlying mechanism. Your provider will be clear about which applies to you.
Nausea is the most commonly reported, and it is often dose related. Flushing and headache also occur. Transient blood pressure changes are documented for this class, which is why uncontrolled hypertension and known cardiovascular disease are contraindications. You will hear all of this before deciding.
Pricing is dose dependent and varies with your protocol and expected frequency of use. We quote after your consultation. Any lab work and follow-up visits are priced separately, and VIP Members receive preferred rates.
No. PT-141 is used situationally, taken ahead of anticipated activity rather than on a daily schedule. Your provider will specify timing and a maximum frequency.
Usually, yes. Low desire commonly traces to testosterone, thyroid, sleep, stress, or medication side effects, and several of those are directly treatable. Prescribing a peptide on top of an untreated hormonal cause is not good medicine, so we look first.
Yes. It is a one-on-one clinical conversation with a licensed provider. Bodyloom is a cash-pay clinic and does not bill insurance, and we treat your information as confidential regardless.
You may contact the Texas Medical Board to verify the Medical Director's license status and for questions or to file a complaint.
Texas Medical Board, MC 263
P.O. Box 2018, Austin, TX 78768-2018
Phone: (800) 201-9353
Fax: (888) 512-2581
Website: www.tmb.state.tx.us
Usted puede comunicarse con la Junta Médica de Texas para verificar el estado de la licencia y para hacer preguntas o presentar una queja.
Junta Médica de Texas, MC 263
P.O. Box 2018, Austin, TX 78768-2018
Teléfono: (800) 201-9353
Fax: (888) 512-2581
Sitio web: www.tmb.state.tx.us